Position in ALT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$93,071
+$41,745 QoQ
Shares Held
30,218
+112.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Derivatives in ALT
reported options exposure · as of Mar 31, 2026CallValue
$15,400
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026HUB Investment Partners, LLC holds $2,329,592 across 7 Biotechnology names. ALT ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,180 | $911,715 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,829 | $816,721 | |
| 3 | TECH |
BIO-TECHNE Corp
|
4,023 | $210,241 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
2,934 | $139,570 | |
| 5 | INCY |
Incyte Corp
|
1,072 | $100,896 | |
| 6 | ALT |
Altimmune, Inc.
This page
|
30,218 | $93,071 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
18,690 | $57,378 |
All Filings in ALT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93,071 | 30,218 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $15,400 | 5,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $14,440 | 4,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $51,326 | 14,218 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||